For the latest in our CEO Spotlight series, we caught up with Dr Tony Coombs, Executive Chairman of Oxford VacMedix - a spinout company making waves in the world of cancer vaccines with its impressive pre-clinical and Phase 1 trial results.
We publish news of technology innovations, investment opportunities, together with updates from spinout & startup companies and licensees
Charting a vibrant future for the Oxford Innovation Society (OIS), Louise Male and Andrea Stewart spark a call to action for a collective, co-created evolution of this historic network. Engage in shaping an innovation hub where useful collaborations, diverse engagements, and a novel digital interface drive the next wave of breakthroughs in Oxford's dynamic ecosystem.
The second year of the Jamies Awards deliver ideas that tackle plastic waste, drug discovery, and bad coffee.
AI-based music generation platform SoulChord takes the crown at this year's Student Entrepreneurship Programme.
From supermarket peas to multi million-dollar deals: Oxford's biotech startups are rewriting the playbook on chronic inflammation, genomic mysteries, and the AI in medicine. Witness how audacious ideas, nurtured in humble settings, mature into world-changing medical innovations in an ecosystem where science, business, and global impact entwine.
Funding via the Connecting Capability Fund will provide acceleration of support for the UK university social venture sector.
Beacon Therapeutics, a pioneering new biotech company, has launched with a mission to restore and improve the vision of patients with retinal diseases. The company is one of the most ambitious spinouts the University has been involved in to date, starting out with an impressive £96 million ($118.5m) in funding, the biggest launch for any company including an Oxford spin-out programme.